Skip to main content
. 2022 Dec 7;2022(12):CD015477. doi: 10.1002/14651858.CD015477

12.

12

Analysis 2.1.2: non‐replicating viral vector vaccine. Outcome: confirmed symptomatic COVID‐19 after complete vaccination.

Voysey 2021a: data pooled from four trials.